ARL3 (NM_004311) Human Recombinant Protein
Product Specifications
Background
ADP-ribosylation factor-like 3 is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL3 binds guanine nucleotides but lacks ADP-ribosylation factor activity. [provided by RefSeq, Jul 2008]
Overview
Recombinant protein of human ADP-ribosylation factor-like 3 (ARL3)
Synonyms
ARFL3; JBTS35; RP83
Gene ID
403
UniProt
P36405
Accession Number mRNA
NM_004311
Chromosomal Location
10q24.32
Expression System
HEK293T
Tag
C-Myc/DDK
Concentration
>50 ug/mL as determined by microplate BCA method
Purity
> 80% as determined by SDS-PAGE and Coomassie blue staining
Form
Liquid
Buffer
25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol
Function
Druggable Genome
Molecular Weight
20.3 kDa
Storage Conditions
Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.
Symbol
ARL3
Species
Human
Protein ID
NP_004302
Gene ID URL
https://www.ncbi.nlm.nih.gov/gene/403
Uniprot URL
https://www.uniprot.org/uniprot/P36405
Accession Number mRNA URL
https://www.ncbi.nlm.nih.gov/nuccore/NM_004311
Protein ID Link
https://www.ncbi.nlm.nih.gov/nuccore/NP_004302
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6282819-01 0.2 mL
CD163L1, CT (CD163L1, CD163B, M160, Scavenger receptor cysteine-rich type 1 protein M160, CD163 antigen-like 1, CD163b) (Biotin)
Ask
View Details 
MBS6282819-02 5x 0.2 mL
CD163L1, CT (CD163L1, CD163B, M160, Scavenger receptor cysteine-rich type 1 protein M160, CD163 antigen-like 1, CD163b) (Biotin)
Ask
View Details 
GTR15120175 1 Vial
Lentiviral human GLMN shRNA (UAS) - Lentiviral human GLMN shRNA (UAS) plasmid
Ask
View Details 302439-AP 200 µL
FATE1 (Fetal and adult Testis-Expressed Transcript Protein, Cancer/Testis antigen 43, CT43, Tumor antigen BJ-HCC-2, FATE1, FATE) (AP) discontinued
Ask
View Details